— Know what they know.
Not Investment Advice
Also trades as: NZYM-B.CO (CPH) · $vol 39M · NSIS-B.CO (CPH) · $vol 36M · NVZMF (OTC) · $vol 0M

NVZMY OTC

Novozymes A/S
1W: -3.7% 1M: -11.6% 3M: -1.6% YTD: +0.4% 1Y: +1.1% 3Y: +59.9% 5Y: -10.5%
$62.60
+0.44 (+0.71%)
 
Weekly Expected Move ±3.3%
$58 $61 $63 $65 $67
OTC · Basic Materials · Chemicals - Specialty · Tech Score Sell · Power 33 · $29.2B mcap · 344M float · 0.0094% daily turnover · Short 24% of daily vol

Cash Flow Trends

Operating Cash Flow
$1.2B +19.8% ▲
5Y CAGR: -22.5%
Capital Expenditures
$471M -30.9% ▼
5Y CAGR: -12.9%
Free Cash Flow
$751M +13.7% ▲
5Y CAGR: -26.1%
Dividends Paid
$403M -61.2% ▼
Buybacks
$100M +0.0% ▲
Net Change in Cash
-$5M -103.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$3.1B$3.7B$3.0B$306M$584M
Depreciation & Amort.$1.4B$1.5B$1.4B$0$575M
Stock-Based Comp.$78M$127M$20M$0$20M
Change in Working Capital-$612M-$583M-$166M$271M$56M
Other Non-Cash Items$34M-$681M-$115M$443M-$13M
Operating Cash Flow$4.1B$4.0B$4.2B$1.0B$1.2B
— Investing Activities —
Capital Expenditures-$1.2B-$2.9B-$1.9B-$338M-$410M
Acquisitions (Net)-$1.6B$190M-$81M$159M-$1.5B
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$124M$28M-$195M-$21M-$41M
Investing Cash Flow-$2.7B-$2.7B-$2.1B-$200M-$2.0B
— Financing Activities —
Net Debt Issuance$758M$418M$865M-$405M$1.2B
Stock Repurchased-$1.5B-$500M$0$0-$100M
Dividends Paid-$1.5B-$1.5B-$2.9B-$250M-$403M
Other Financing$622M$357M$80M-$86M$0
Financing Cash Flow-$1.6B-$1.2B-$1.9B-$703M$753M
Net Change in Cash-$218M$78M$75M$130M-$5M
Cash End of Period$963M$1.0B$1.1B$280M$275M
Free Cash Flow$2.8B$1.1B$2.1B$660M$751M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms